| Financial Year |
March 31 2023 |
| Monetary Funds |
2,790,922,647.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
137,239,609.12 |
| Accounts Receivable |
3,153,851,874.84 |
| Advances to Suppliers |
32,971,163.51 |
| Other Receivables |
570,844,625.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
142,758,366.60 |
| Inventories |
2,583,517,022.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
153,654,342.94 |
| Total Current Assets |
9,461,992,693.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,416,872,753.75 |
| Investment Properties |
3,245,573,300.00 |
| Fixed Assetes |
1,900,804,471.49 |
| Under-construction Projects |
48,669,202.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
664,532,709.06 |
| R&D expenses |
341,474,419.32 |
| Goodwill |
287,700,618.58 |
| Long-Term Deferred and Prepaid Expenses |
1,374,553.56 |
| Deferred Income Tax Assets |
844,665,832.99 |
| Other Non-Current Assets |
1,920,870.01 |
| Sub-Total of Non-Current Assets |
11,764,378,365.05 |
| Total Assets |
21,226,371,058.51 |
| Short-Term Loans |
3,766,399.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
707,244,546.35 |
| Accounts Payable |
3,291,887,963.98 |
| Accounts Received In Advance |
41,231,003.36 |
| Employee Compensation Payable |
31,131,184.55 |
| Taxes Payable |
33,829,017.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,141,105,805.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
660,370,796.09 |
| Other Current Liabilities |
187,176,932.84 |
| Sub-Total of Current Liabilities |
6,695,478,580.42 |
| Long-term Loans |
2,164,492,667.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
46,060,600.95 |
| Deferred Income Tax Liabilities |
657,162,129.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,871,201,187.09 |
| Total Liabilities |
9,566,679,767.51 |
| Paid-In Capital(Or Share Stock) |
4,571,523,000.00 |
| Capital Surplus |
8,726,047,915.19 |
| Surplus Reserve |
426,993,753.64 |
| LESS:Treasury Stock |
314,849,289.00 |
| Undistributed Profits |
-2,810,590,166.71 |
| Minority Stockholder's Interest |
1,392,033,483.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,267,657,807.47 |
| Owner's Equity（Stockholder's Equity） |
11,659,691,291.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,226,371,058.51 |
